Expert judgement in pharmacoeconomic studies. Guidance and future use.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 10977393)

Published in Pharmacoeconomics on June 01, 2000

Authors

C Evans1, B Crawford

Author Affiliations

1: MAPI Values USA, Boston, Massachusetts, USA. chris.evans@mapivaluesusa.com

Articles by these authors

THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. J Clin Invest (1945) 27.11

Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery. Ann Surg Oncol (2000) 1.98

Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. Br J Ophthalmol (1999) 1.87

Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity. Pharmacoeconomics (1999) 1.71

Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum (2000) 1.71

A systematic approach to spinal reconstruction after anterior decompression for neoplastic disease of the thoracic and lumbar spine. Neurosurgery (1993) 1.52

Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum (1999) 1.38

An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum (2003) 1.25

Lettuce infectious yellows virus: in vitro acquisition analysis using partially purified virions and the whitefly Bemisia tabaci. J Gen Virol (1999) 1.25

Use of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseases. Ann Rheum Dis (2009) 1.25

Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis. Rheumatology (Oxford) (2004) 1.09

Shuttling of CTP:Phosphocholine cytidylyltransferase between the nucleus and endoplasmic reticulum accompanies the wave of phosphatidylcholine synthesis during the G(0) --> G(1) transition. J Biol Chem (1999) 1.08

Cloned pigmented retinal cells; the affects of cytochalasin B on ultrastructure and behavior. Z Zellforsch Mikrosk Anat (1972) 1.05

Heterotopic adipose tissue and smooth muscle in the optic disc: association with isolated colobomas. Arch Ophthalmol (1972) 1.01

Asynchronous accumulation of lettuce infectious yellows virus RNAs 1 and 2 and identification of an RNA 1 trans enhancer of RNA 2 accumulation. J Virol (2000) 1.00

Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS). Int J Lab Hematol (2007) 0.91

Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo. Lupus (2003) 0.89

Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block. J Rheumatol (1994) 0.87

Selection of glycosaminoglycan-deficient mutants. Methods Mol Biol (2001) 0.85

Management of carotid-cavernous fistulas by surgery combined with interventional radiology. Report of two cases. J Neurosurg (1983) 0.85

Cloned pigmented retinal epiehtlium. The role of microfilaments in the differentiation of cell shape. J Cell Biol (1979) 0.84

Psychological adaptation to pregnancy in childless women more than 35 years of age. Am J Obstet Gynecol (1987) 0.83

Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires. Acta Otolaryngol (2005) 0.82

Homozygosity for a 4-bp deletion in a patient with Wolfram syndrome suggesting possible phenotype and genotype correlation. Clin Genet (2001) 0.81

Unique aspects of caring for dying children and their families. Am J Hosp Palliat Care (2002) 0.78

Autosomal dominant (adult) polycystic kidney disease in childhood. Conn Med (1980) 0.78

Refractive changes induced by intraocular lens tilt and longitudinal displacement. Arch Ophthalmol (1986) 0.78

Hepatic necrosis associated with halothane anesthesia in an alpaca. Can Vet J (1995) 0.75

Educational Approach to Menopausal Distress: Pilot study of patient workshops. Can Fam Physician (1992) 0.75

Renal function, microcirculation, and the role of PGI2 following atheromatous embolization. Curr Surg (1983) 0.75

Leiomyosarcoma of the subclavian artery. J Vasc Surg (1995) 0.75

Criminalization of the mentally ill. Can J Psychiatr Nurs (1988) 0.75

Deaths in a youth program. Ment Hyg (1970) 0.75

The dawn of a deluge. Women Alive (2000) 0.75

Treatment of caroticocavernous fistulae with detachable balloons introduced by percutaneous catheterization. Med J Aust (1983) 0.75

A web page to teach neurology and neuropathology to medical students. Neuropathol Appl Neurobiol (2001) 0.75

Not bad, just misunderstood. Nurs Times (2000) 0.75

The development of the baboon prostate: ultrasound methodology, modelling, and natural history. J Androl (1996) 0.75

Teaching because we care. Times (1980) 0.75

Staff participation in patient recretion. Hosp Community Psychiatry (1971) 0.75

Comprehensive quality measurement in the hospital emergency department. Top Health Rec Manage (1990) 0.75

Anatomic contribution to differences in rabbit colonic muscle contraction. Gastroenterology (1991) 0.75

Hormone replacement therapy and breast cancer risk. Cancer Pract (1997) 0.75

Cryotherapy of stromal herpes simplex keratitis in rabbits. Am J Ophthalmol (1971) 0.75

Data collection methods in prospective economic evaluations: how accurate are the results? Value Health (2006) 0.75